{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:59:30Z","timestamp":1760061570128,"version":"3.41.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,28]]},"DOI":"10.7759\/cureus.88907","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T14:22:31Z","timestamp":1753712551000},"source":"Crossref","is-referenced-by-count":1,"title":["Candida parapsilosis Fungemia in a Patient With Spinal Cord Injury on Sodium-Glucose Cotransporter-2 Inhibitor Therapy: A Case Report"],"prefix":"10.7759","author":[{"given":"Ashley E","family":"Traczuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Stillman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/HCR.0b013e3181f68aba","article-title":"Cardiometabolic risk in community-dwelling persons with chronic spinal cord injury","volume":"31","author":"Groah SL","year":"2011","unstructured":"Groah SL, Nash MS, Ward EA, et al.. Cardiometabolic risk in community-dwelling persons with chronic spinal cord injury. J Cardiopulm Rehabil Prev. 2011, 31:73-80. 10.1097\/HCR.0b013e3181f68aba","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2007.05.023","article-title":"Different risk factor patterns for metabolic syndrome in men with spinal cord injury compared with able-bodied men despite similar prevalence rates","volume":"88","author":"Liang H","year":"2007","unstructured":"Liang H, Chen D, Wang Y, Rimmer JH, Braunschweig CL. Different risk factor patterns for metabolic syndrome in men with spinal cord injury compared with able-bodied men despite similar prevalence rates. Arch Phys Med Rehabil. 2007, 88:1198-204. 10.1016\/j.apmr.2007.05.023","journal-title":"Arch Phys Med Rehabil"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1310\/sci1903-183","article-title":"Cardiometabolic risk clustering in spinal cord injury: results of exploratory factor analysis","volume":"19","author":"Libin A","year":"2013","unstructured":"Libin A, Tinsley E, Nash M, et al.. Cardiometabolic risk clustering in spinal cord injury: results of exploratory factor analysis. Top Spinal Cord Inj Rehabil. 2013, 19:183-94. 10.1310\/sci1903-183","journal-title":"Top Spinal Cord Inj Rehabil"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000436074.98534.6e","article-title":"Spinal cord injury and type 2 diabetes. Results from a population health survey","volume":"81","author":"Cragg JJ","year":"2013","unstructured":"Cragg JJ, Noonan VK, Dvorak M, Krassioukov A, Mancini GB, Borisoff JF. Spinal cord injury and type 2 diabetes. Results from a population health survey. Neurology. 2013, 81:1864-8. 10.1212\/01.wnl.0000436074.98534.6e","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2337\/diab.29.11.906","article-title":"Glucose intolerance due to insulin resistance in patients with spinal cord injuries","volume":"29","author":"Duckworth WC","year":"1980","unstructured":"Duckworth WC, Solomon SS, Jallepalli P, Heckemeyer C, Finnern J, Powers A. Glucose intolerance due to insulin resistance in patients with spinal cord injuries. Diabetes. 1980, 29:906-10. 10.2337\/diab.29.11.906","journal-title":"Diabetes"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/10400435.1999.10131993","article-title":"Metabolic and endocrine changes in persons aging with spinal cord injury","volume":"11","author":"Bauman WA","year":"1999","unstructured":"Bauman WA, Spungen AM, Adkins RH, Kemp BJ. Metabolic and endocrine changes in persons aging with spinal cord injury. Assist Technol. 1999, 11:88-96. 10.1080\/10400435.1999.10131993","journal-title":"Assist Technol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(94)90126-0","article-title":"Disorders of carbohydrate and lipid metabolism in veterans with paraplegia or quadriplegia: a model of premature aging","volume":"43","author":"Bauman WA","year":"1994","unstructured":"Bauman WA, Spungen AM. Disorders of carbohydrate and lipid metabolism in veterans with paraplegia or quadriplegia: a model of premature aging. Metabolism. 1994, 43:749-756. 10.1016\/0026-0495(94)90126-0","journal-title":"Metabolism"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020494","article-title":"Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences","volume":"21","author":"Hong SH","year":"2020","unstructured":"Hong SH, Choi KM. Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences. Int J Mol Sci. 2020, 21:494. 10.3390\/ijms21020494","journal-title":"Int J Mol Sci"},{"key":"ref9","unstructured":"Patient-Centered Outcomes Research Institute. Comparing bladder management strategies for people with spinal cord injuries. (2019). Accessed. September 2024: https:\/\/www.pcori.org\/research-results\/2015\/comparing-bladder-management-strategies-people-spinal-cord-injuries."},{"key":"ref10","article-title":"Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers","volume":"29","author":"Consortium for Spinal Cord Medicine","year":"2006","unstructured":"Consortium for Spinal Cord Medicine. Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers. J Spinal Cord Med. 2006, 29:527-73.","journal-title":"J Spinal Cord Med"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-5347(05)67157-1","article-title":"Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury","volume":"164","author":"Esclar\u00edn De Ruz A","year":"2000","unstructured":"Esclar\u00edn De Ruz A, Garc\u00eda Leoni E, Herruzo Cabrera R. Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. J Urol. 2000, 164:1285-9.","journal-title":"J Urol"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.2337\/dci23-0065","article-title":"Expanding the use of SGLT2i in diabetes beyond type 2","volume":"47","author":"Giaccari A","year":"2024","unstructured":"Giaccari A. Expanding the use of SGLT2i in diabetes beyond type 2. Diabetes Care. 2024, 47:50-1.","journal-title":"Diabetes Care"},{"key":"ref13","article-title":"Effects of SGLT2 inhibitors on UTIs and genital infections in type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"7","author":"Liu J","year":"2017","unstructured":"Liu J, Li L, Li S, Jia P, Deng K, Chen W, Sun X. Effects of SGLT2 inhibitors on UTIs and genital infections in type 2 diabetes mellitus: a systematic review and meta-analysis. Sci Rep. 2017, 7:2824.","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1007\/s00592-018-1116-0","article-title":"SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials","volume":"55","author":"Puckrin R","year":"2018","unstructured":"Puckrin R, Saltiel MP, Reynier P, Azoulay L, Yu OH, Filion KB. SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials. Acta Diabetol. 2018, 55:503-14.","journal-title":"Acta Diabetol"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1177\/08971900241229107","article-title":"Risk of urinary infections in veterans on empagliflozin with concurrent catheter use","volume":"37","author":"Hopper RA","year":"2024","unstructured":"Hopper RA, McMahan DM, Jarvis KA, Weideman RA. Risk of urinary infections in veterans on empagliflozin with concurrent catheter use. J Pharm Pract. 2024, 37:1127-31.","journal-title":"J Pharm Pract"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-021-05982-3","article-title":"Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports","volume":"21","author":"Bartolo C","year":"2021","unstructured":"Bartolo C, Hall V, Friedman ND, Lanyon C, Fuller A, Morrissey CO, Athan E. Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports. BMC Infect Dis. 2021, 21:284.","journal-title":"BMC Infect Dis"},{"key":"ref17","article-title":"Sodium-glucose co-transporter-2 inhibitors causing Candida tropicalis fungemia and renal abscess","volume":"2","author":"Simhadri PK","year":"2024","unstructured":"Simhadri PK, Vaitla P, Sriperumbuduri S, Chandramohan D, Singh P, Murari U. Sodium-glucose co-transporter-2 inhibitors causing Candida tropicalis fungemia and renal abscess. JCEM Case Rep. 2024, 2:luae010.","journal-title":"JCEM Case Rep"},{"key":"ref18","article-title":"Culture media influences Candida parapsilosis growth, susceptibility, and virulence","volume":"13","author":"Ar\u00e9valo-Jaimes BV","year":"2023","unstructured":"Ar\u00e9valo-Jaimes BV, Admella J, Blanco-Cabra N, Torrents E. Culture media influences Candida parapsilosis growth, susceptibility, and virulence. Front Cell Infect Microbiol. 2023, 13:1323619.","journal-title":"Front Cell Infect Microbiol"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00013-08","article-title":"Candida parapsilosis, an emerging fungal pathogen","volume":"21","author":"Trofa D","year":"2008","unstructured":"Trofa D, G\u00e1cser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev. 2008, 21:606-25.","journal-title":"Clin Microbiol Rev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-018-0016-2","article-title":"Glucagon-like peptide 1 in health and disease","volume":"14","author":"Andersen A","year":"2018","unstructured":"Andersen A, Lund A, Knop FK, Vilsb\u00f8ll T. Glucagon-like peptide 1 in health and disease. Nat Rev Endocrinol. 2018, 14:390-403. 10.1038\/s41574-018-0016-2","journal-title":"Nat Rev Endocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/354161-candida-parapsilosis-fungemia-in-a-patient-with-spinal-cord-injury-on-sodium-glucose-cotransporter-2-inhibitor-therapy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T14:22:34Z","timestamp":1753712554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/354161-candida-parapsilosis-fungemia-in-a-patient-with-spinal-cord-injury-on-sodium-glucose-cotransporter-2-inhibitor-therapy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.88907","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,28]]}}}